Allurion Technologies (ALURD) Cash & Equivalents Growth (3y) (2025)

Allurion Technologies (ALURD) Cash & Equivalents Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 186.78 Bn 179.48 Bn 6.27 Bn -9.44%
2 Stryker 131.95 Bn 129.07 Bn 3.81 Bn 19.87%
3 Medtronic 111.27 Bn 102.05 Bn 6.41 Bn 8.10%
4 Boston Scientific 68.58 Bn 67.13 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 48.31 Bn 44.63 Bn 1.29 Bn 40.99%
6 GE HealthCare Technologies 29.23 Bn 26.94 Bn 1.98 Bn -0.70%
7 Dexcom 28.90 Bn 27.78 Bn 750.30 Mn 21.52%
8 Smith & Nephew 28.19 Bn 27.62 Bn - 16.75%
9 Koninklijke Philips 24.33 Bn 21.29 Bn 2.01 Bn 30.29%
10 Allurion Technologies 60.75 Mn 55.69 Mn 1.23 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -11.03%